(Q40077852)

17 September 2017

Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines (English)

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

28 May 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194711

complement system proteins

28 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194711

28 December 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

28 December 2022

author name string

E. Yefenof

1

0 references

G. Klein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194711

28 December 2022

K. Kvarnung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194711

28 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=194711

28 May 2022

publication date

1 June 1977

1 reference

17 September 2017

15 June 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=194711

full work available at URL

28 December 2022

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0008874977900247?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

https://api.elsevier.com/content/article/PII:0008874977900247?httpAccept=text/plain

28 December 2022

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

28 December 2022

1 reference

17 September 2017

31

1 reference

17 September 2017

225-233

1 reference

17 September 2017

2

1 reference

Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum

28 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane

28 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

28 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Surface markers on human B- and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines

28 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance

28 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells

28 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis

28 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis

28 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Demonstration of complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography

28 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

28 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

28 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

28 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

28 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0008-8749(77)90024-7

28 December 2022

Identifiers

1 reference

17 September 2017

1 reference